You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor–Modified T Cells After Failure of Ibrutinib
|
|---|---|
| Published in |
Journal of Clinical Oncology, July 2017
|
| DOI | 10.1200/jco.2017.72.8519 |
| Pubmed ID | |
| Authors |
Cameron J Turtle, Kevin A Hay, Laïla-Aïcha Hanafi, Daniel Li, Sindhu Cherian, Xueyan Chen, Brent Wood, Arletta Lozanski, John C Byrd, Shelly Heimfeld, Stanley R Riddell, David G Maloney |
X Demographics
The data shown below were collected from the profiles of 71 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 28 | 39% |
| Spain | 4 | 6% |
| United Kingdom | 4 | 6% |
| India | 2 | 3% |
| Ireland | 2 | 3% |
| Mexico | 2 | 3% |
| Russia | 2 | 3% |
| Brazil | 2 | 3% |
| Canada | 1 | 1% |
| Other | 4 | 6% |
| Unknown | 20 | 28% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 47 | 66% |
| Practitioners (doctors, other healthcare professionals) | 11 | 15% |
| Scientists | 11 | 15% |
| Science communicators (journalists, bloggers, editors) | 2 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 425 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 425 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 67 | 16% |
| Student > Bachelor | 48 | 11% |
| Student > Ph. D. Student | 46 | 11% |
| Other | 37 | 9% |
| Student > Master | 30 | 7% |
| Other | 87 | 20% |
| Unknown | 110 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 147 | 35% |
| Immunology and Microbiology | 42 | 10% |
| Biochemistry, Genetics and Molecular Biology | 35 | 8% |
| Agricultural and Biological Sciences | 23 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 20 | 5% |
| Other | 38 | 9% |
| Unknown | 120 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 207. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 April 2024.
All research outputs
#192,586
of 25,734,859 outputs
Outputs from Journal of Clinical Oncology
#340
of 22,220 outputs
Outputs of similar age
#3,831
of 308,280 outputs
Outputs of similar age from Journal of Clinical Oncology
#13
of 164 outputs
Altmetric has tracked 25,734,859 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,220 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 308,280 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 164 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.